Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the pharma industry. This time, you get to discover 5 hand-picked startups developing pharmacogenomics.
Global Startup Heat Map highlights 5 Top Pharmacogenomics Solutions out of 167
The insights of this data-driven analysis are derived from the Big Data & Artificial Intelligence-powered StartUs Insights Discovery Platform, covering 2.093.000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies & relevant startups within a specific field in just a few clicks.
The Global Startup Heat Map below reveals the distribution of the 167 exemplary startups & scaleups we analyzed for this research. Further, it highlights 5 pharma startups that we hand-picked based on criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these 5 startups & scaleups in this report. For insights on the other 162 pharmacogenomics solutions, get in touch.
Prairie Health offers Pharmacogenomic Testing
Different people react to the same drug differently. This is particularly the case for mental health medications as an identical medicine that may work effectively for one patient shows no effects for another. Pharmacogenomics provides insights into how the body metabolizes medications. This enables the development of treatment regimens that work appropriately for each patient.
Prairie Health is a US-based data-driven telemedicine startup. The startup offers a saliva-based genetic test that helps psychiatrists build a personalized treatment plan. This allows them to make informed decisions on which drugs to prescribe to avoid side effects and bad reactions. The startup’s solution is a shift from the trial-and-error approach in psychiatry, leading to greater reductions in symptoms of anxiety and depression.
NalaGenetics develops Personalized Dosing Solutions
Drugs that are ineffective for some patient subgroups lower patient outcomes, as well as lead to high medical costs and adverse events. Pharmacogenomics solutions identify specific drug-gene interactions in individuals. This allows doctors to prescribe the most appropriate doses to optimize therapeutic results while minimizing adverse events.
Singaporean startup NalaGenetics offers personalized dosing and prescription solutions. The startup’s pharmacogenomics kit provides actionable insights on the use of up to 159 different drugs. These include medications for a wide range of conditions, including cardiac, pain, gastric, and other chronic disorders. The startup provides post-test counseling and a mobile app for continuous support to ensure better decisions for current and future prescriptions.
Dalcor Pharmaceuticals advances Precision Medicine
In recent years, there has been a shift from a ‘one drug fits all’ approach to a patient-oriented approach. The major factors driving this transition are the falling costs of human genomics and pharmacogenomics. As a result, startups are leveraging these technologies to provide precision medicine. Such solutions take into account PGx markers and clinical data to predict the response of patients to different therapeutic interventions.
Canadian startup Dalcor Pharmaceuticals develops precision medicine solutions for cardiovascular disease (CVD). Dalcetrapib, the startup’s lead drug candidate, reduces the risk of major adverse cardiovascular events (MACE). It works for patients with an AA polymorphism, a genotype that is present in nearly 20% of all patients with CVD. The startup is also investigating the drug as a potential oral antiviral treatment for COVID-19.
Phenomics Health provides Phenome Analysis
BioTech startups are leveraging advances in sequencing and use machine learning for big biological data. This enables researchers to predict all possible phenotypes for an individual. By studying how drugs interact with genes, startups analyze 3D and 4D networks of drug mechanisms. This allows pharma companies to identify new medications, as well as support clinical trials for new or repurposed drugs.
Phenomics Health is a US-based startup that offers a precision medicine platform. The startup’s patented phenomy analytics platform leverages machine learning and bioinformatics to improve precision in treatment. It analyzes patient-specific and population-level medical big data to support clinical decisions. This provides an actionable clinical patient profile and enables evidence-based interventions across many therapeutic classes.
Fagron Genomics delivers Preventive Treatment
Beyond making medicine more precise, advances in omics technologies are contributing to the shift to predictive, preventive, personalized, and participatory (P4) medicine as well. Preventive treatments identify individuals that are susceptible to certain diseases and recommend prophylactic interventions. With pharmacogenomics, BioTech startups develop personalized plans for individuals who are genetically predisposed to diseases.
Spanish startup Fagron Genomics advances preventive medicine based on pharmacogenomics. The startup’s testing kit, TrichoTest, analyzes 13 genes and 48 genetic variations that contribute to alopecia. This provides insights into prostaglandins metabolism, androgenic effect, collagen synthesis, and multiple other factors. The test is particularly useful for patients with a family history of the diseases, as well as those who have tried different treatments without much success.
Discover more Pharma Startups
Pharma startups such as the examples highlighted in this report focus on precision medicine, personalized treatments, robotics as well as connected medical devices. While all of these technologies play a major role in advancing the pharma industry, they only represent the tip of the iceberg. To explore more pharma technologies, simply get in touch to let us look into your areas of interest. For a more general overview, you can download our free Pharma Innovation Report to save your time and improve strategic decision-making.